These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Anti-B-Cell Therapies in Autoimmune Neurological Diseases: Rationale and Efficacy Trials. Alexopoulos H; Biba A; Dalakas MC Neurotherapeutics; 2016 Jan; 13(1):20-33. PubMed ID: 26566961 [TBL] [Abstract][Full Text] [Related]
5. B cell immunobiology in disease: evolving concepts from the clinic. Martin F; Chan AC Annu Rev Immunol; 2006; 24():467-96. PubMed ID: 16551256 [TBL] [Abstract][Full Text] [Related]
7. Regulatory B cells in skin and connective tissue diseases. Fujimoto M J Dermatol Sci; 2010 Oct; 60(1):1-7. PubMed ID: 20832998 [TBL] [Abstract][Full Text] [Related]
8. Splenic Long-Lived Plasma Cells Promote the Development of Follicular Helper T Cells during Autoimmune Responses. Jang E; Cho WS; Oh YK; Cho ML; Kim JM; Paik DJ; Youn J J Immunol; 2016 Feb; 196(3):1026-35. PubMed ID: 26729802 [TBL] [Abstract][Full Text] [Related]
9. High level expression of the plasma cell antigen PC.1 on the T-cell subset expanding in MRL/MpJ-lpr/lpr mice: detection with a xenogeneic monoclonal antibody and alloantisera. Dumont FJ; Habbersett RC; Coker LZ; Nichols EA; Treffinger JA Cell Immunol; 1985 Dec; 96(2):327-37. PubMed ID: 2943419 [TBL] [Abstract][Full Text] [Related]
10. Innate responses of B cells. Gray D; Gray M; Barr T Eur J Immunol; 2007 Dec; 37(12):3304-10. PubMed ID: 18000957 [TBL] [Abstract][Full Text] [Related]
11. Not always the bad guys: B cells as regulators of autoimmune pathology. Fillatreau S; Gray D; Anderton SM Nat Rev Immunol; 2008 May; 8(5):391-7. PubMed ID: 18437156 [TBL] [Abstract][Full Text] [Related]
12. The advent of monoclonal antibodies in the treatment of chronic autoimmune diseases. Bruno V; Battaglia G; Nicoletti F Neurol Sci; 2011 Jan; 31 Suppl 3():283-8. PubMed ID: 20644974 [TBL] [Abstract][Full Text] [Related]
13. Targeting B Cells and Plasma Cells in Autoimmune Diseases. Hofmann K; Clauder AK; Manz RA Front Immunol; 2018; 9():835. PubMed ID: 29740441 [TBL] [Abstract][Full Text] [Related]
14. B-cell-directed therapy for inflammatory skin diseases. Nagel A; Hertl M; Eming R J Invest Dermatol; 2009 Feb; 129(2):289-301. PubMed ID: 19148218 [TBL] [Abstract][Full Text] [Related]
15. B cell-ablative therapy for the treatment of autoimmune diseases. Patel DD Arthritis Rheum; 2002 Aug; 46(8):1984-5. PubMed ID: 12209499 [No Abstract] [Full Text] [Related]
16. Plasma cells as an innovative target in autoimmune disease with renal manifestations. Hiepe F; Radbruch A Nat Rev Nephrol; 2016 Apr; 12(4):232-40. PubMed ID: 26923204 [TBL] [Abstract][Full Text] [Related]
17. The role of APRIL - A proliferation inducing ligand - In autoimmune diseases and expectations from its targeting. Baert L; Manfroi B; Casez O; Sturm N; Huard B J Autoimmun; 2018 Dec; 95():179-190. PubMed ID: 30385081 [TBL] [Abstract][Full Text] [Related]
18. B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases. Uzzan M; Colombel JF; Cerutti A; Treton X; Mehandru S Dig Dis Sci; 2016 Dec; 61(12):3407-3424. PubMed ID: 27655102 [TBL] [Abstract][Full Text] [Related]
19. B-lymphocyte effector functions in health and disease. DiLillo DJ; Horikawa M; Tedder TF Immunol Res; 2011 Apr; 49(1-3):281-92. PubMed ID: 21125343 [TBL] [Abstract][Full Text] [Related]
20. [CD20 antibody for the treatment of systemic autoimmune diseases]. Tanaka Y Nihon Rinsho; 2005 May; 63 Suppl 5():728-33. PubMed ID: 15954437 [No Abstract] [Full Text] [Related] [Next] [New Search]